Home » Topics » Regulatory

Regulatory
RSS

FDA approval for new formulation of Visicol

March 18, 2002

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

Extended-release Zerit has similar virological activity to immediate-release drug

March 15, 2002

CPMP recommends approval of irbesartan in diabetic renal disease

March 13, 2002

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002

CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies

March 8, 2002

AstraZeneca submits sNDA for Arimidex in early breast cancer

March 6, 2002

Connetics' sNDA for Olux accepted by FDA

March 5, 2002

FDA approves Remicade for improvement of physical function in RA

March 5, 2002

NDA filed for Zomig Nasal Spray

March 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...